Sfoglia per Autore
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target?
2016 L. Valenti, M. Meroni, R. Rametta, P. Dongiovanni
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage
2016 B. Donati, B.M. Motta, P. Pingitore, M. Meroni, A. Pietrelli, A. Alisi, S. Petta, C. Xing, P. Dongiovanni, B. Del Menico, R. Rametta, R.M. Mancina, S. Badiali, A.L. Fracanzani, A. Craxì, S. Fargion, V. Nobili, S. Romeo, L. Valenti
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
2016 R.M. Mancina, P. Dongiovanni, S. Petta, P. Pingitore, M. Meroni, R. Rametta, J. Borén, T. Montalcini, A. Pujia, O. Wiklund, G. Hindy, R. Spagnuolo, B.M. Motta, R.M. Pipitone, A. Craxì, S. Fargion, V. Nobili, P. Käkelä, V. Kärjä, V. Männistö, J. Pihlajamäki, D.F. Reilly, J. Castro Perez, J. Kozlitina, L. Valenti, S. Romeo
Liver fat accumulation is associated with circulating PCSK9
2016 M. Ruscica, N. Ferri, C. Macchi, M. Meroni, C. Lanti, C. Ricci, M. Maggioni, A.L. Fracanzani, S. Badiali, S. Fargion, P. Magni, L. Valenti, P. Dongiovanni
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis
2016 P. Pingitore, P. Dongiovanni, B.M. Motta, M. Meroni, S.M. Lepore, R.M. Mancina, S. Pelusi, C. Russo, A. Caddeo, G. Rossi, T. Montalcini, A. Pujia, O. Wiklund, L. Valenti, S. Romeo
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease
2017 P. Dongiovanni, M. Meroni, G.A. Baselli, G.A. Bassani, R. Rametta, A. Pietrelli, M. Maggioni, F. Facciotti, V. Trunzo, S. Badiali, S. Fargion, S. Gatti, L.V.C. Valenti
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease
2017 S. Petta, L. Valenti, G. Svegliati Baroni, M. Ruscica, R.M. Pipitone, P. Dongiovanni, C. Rychlicki, N. Ferri, C. Cammà, A.L. Fracanzani, I. Pierantonelli, V. Di Marco, M. Meroni, D. Giordano, S. Grimaudo, M. Maggioni, D. Cabibi, S. Fargion, A. Craxì
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
2017 B. Donati, P. Dongiovanni, S. Romeo, M. Meroni, M. Mccain, L. Miele, S. Petta, S. Maier, C. Rosso, L. De Luca, E. Vanni, S. Grimaudo, R. Romagnoli, F. Colli, F. Ferri, R.M. Mancina, P. Iruzubieta, A. Craxi, A.L. Fracanzani, A. Grieco, S.G. Corradini, A. Aghemo, M. Colombo, G. Soardo, E. Bugianesi, H. Reeves, Q.M. Anstee, S. Fargion, L. Valenti
Notch signaling and progenitor/ductular reaction in steatohepatitis
2017 C.M. Morell, R. Fiorotto, M. Meroni, A. Raizner, B. Torsello, M. Cadamuro, G. Spagnuolo, E. Kaffe, S. Sutti, E. Albano, M. Strazzabosco
DOWN-REGULATION OF HEPATIC MBOAT7 BY HYPERINSULINEMIA FAVORS STEATOSIS DEVELOPMENT
2018 M. Meroni
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
2018 P. Dongiovanni, M. Meroni, R.M. Mancina, G. Baselli, R. Rametta, S. Pelusi, V. Männistö, A.L. Fracanzani, S. Badiali, L. Miele, S. Grimaudo, S. Petta, E. Bugianesi, G. Soardo, S. Fargion, J. Pihlajamäki, S. Romeo, L. Valenti
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
2018 C. Zhu, K. Kim, X. Wang, A. Bartolome, M. Salomao, P. Dongiovanni, M. Meroni, M.J. Graham, K.P. Yates, A.M. Diehl, R.F. Schwabe, I. Tabas, L. Valenti, J.E. Lavine, U.B. Pajvani
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis
2018 P. Dongiovanni, M. Meroni, M. Longo, S. Fargion, A.L. Fracanzani
The role of probiotics in nonalcoholic fatty liver disease : A new insight into therapeutic strategies
2019 M. Meroni, M. Longo, P. Dongiovanni
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2019 S. Pelusi, G. Baselli, A. Pietrelli, P. Dongiovanni, B. Donati, M.V. Mccain, M. Meroni, A.L. Fracanzani, R. Romagnoli, S. Petta, A. Grieco, L. Miele, G. Soardo, E. Bugianesi, S. Fargion, A. Aghemo, R. D'Ambrosio, C. Xing, S. Romeo, R. De Francesco, H.L. Reeves, L.V.C. Valenti
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients
2019 P. Dongiovanni, M. Meroni, G. Baselli, R.M. Mancina, M. Ruscica, M. Longo, R. Rametta, A. Cespiati, S. Pelusi, N. Ferri, V. Ranzani, V. Nobili, J. Pihlajamaki, A.L. Fracanzani, S. Badiali, S. Petta, S. Fargion, S. Romeo, J. Kozlitina, L. Valenti
Alcohol or gut microbiota : who is the guilty?
2019 M. Meroni, M. Longo, P. Dongiovanni
Mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance
2019 M. Meroni, M. Longo, V. Erconi, L. Valenti, S. Gatti, A.L. Fracanzani, P. Dongiovanni
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort
2020 Q.M. Anstee, R. Darlay, S. Cockell, M. Meroni, O. Govaere, D. Tiniakos, A.D. Burt, P. Bedossa, J. Palmer, Y. Liu, G.P. Aithal, M. Allison, H. Yki-Järvinen, M. Vacca, J. Dufour, P. Invernizzi, D. Prati, M. Ekstedt, S. Kechagias, S. Francque, S. Petta, E. Bugianesi, K. Clement, V. Ratziu, J.M. Schattenberg, L. Valenti, C.P. Day, H.J. Cordell, A.K. Daly
MAFLD in COVID-19 patients: an insidious enemy
2020 P. Dongiovanni, M. Meroni, M. Longo, A.L. Fracanzani
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile